Skip to main content
Clinical Trials/NCT05323695
NCT05323695
Completed
Not Applicable

Implementation of a Depression Screening Intervention at a Transgender Health Clinic in Thailand

Thai Red Cross AIDS Research Centre1 site in 1 country317 target enrollmentOctober 11, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depressive Symptoms
Sponsor
Thai Red Cross AIDS Research Centre
Enrollment
317
Locations
1
Primary Endpoint
Number of participants screening positive for depression
Status
Completed
Last Updated
last year

Overview

Brief Summary

The study aims to develop and implement a depression screening intervention into routine HIV and sexual health service provision at a transgender health clinic in Thailand, and to explore the facilitators, barriers, feasibility and acceptability of the screening implementation.

Detailed Description

The study will follow a mixed-methods approach that will incorporate quantitative and qualitative components. Aim 1 will involve the development and implementation of depression screening intervention at Tangerine Clinic. Aim 2 will involve semi-structured interviews with a purposive subset of participants who received the intervention and healthcare providers to explore the multilevel facilitators, barriers, feasibility and acceptability of the screening implementation. Aim 3 will evaluate the proportion of participants who are offered, accept, and receive the peer-led depression screening intervention, and the proportion who screen positive.

Registry
clinicaltrials.gov
Start Date
October 11, 2021
End Date
July 2, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Thai nationality
  • Transgender women ≥18 years
  • Attending the Tangerine Clinic for routine care visits during the intervention period.
  • Can be a new or returning clients.

Exclusion Criteria

  • Transgender women currently receiving care for a mental health diagnosis will be excluded from participating in this study.
  • Inclusion Criteria for healthcare providers:
  • Currently working at the Tangerine Clinic
  • Can be medical doctors, nurses, peer counselors and other members of the clinic management team involved in the routine delivery of HIV and health services to Transgender women.
  • Exclusion criteria for healthcare providers
  • Not willing to participate in this study

Outcomes

Primary Outcomes

Number of participants screening positive for depression

Time Frame: Day 1

Screening positive is defined as scoring 7 or greater on PHQ-9. The total possible score for PHQ-9 is 27, with 0-6 being minimum and indicating no depressive symptoms, 7-12 mild depression, 13-18 moderate depression, and 19-27 severe depression.

Intervention Acceptability: Participants' perspective of the intervention through focus group discussion

Time Frame: Day 1

Acceptability will be assessed qualitatively through post-intervention focus group discussion.

Intervention Feasibility: Number of intervention completed

Time Frame: Day 1

Feasibility will be measured by number of intervention completed. Point estimates of \>50% of participants completed is considered as the minimum criteria for feasibility.

Intervention Feasibility: Participants' perspective of the intervention through focus group discussion.

Time Frame: Day 1

Feasibility will be assessed qualitatively through post-intervention focus group discussion.

Intervention Acceptability: Number of participants who accepted intervention

Time Frame: Day 1

Acceptability will be measured by the number of clients who were offered and accepted the intervention.

Intervention Acceptability: Participants' perspective of the intervention through in-depth interviews

Time Frame: Day 1

Acceptability will be assessed qualitatively through post-intervention in-depth interviews.

Intervention Feasibility: Participants' perspective of the intervention through in-depth interviews

Time Frame: Day 1

Feasibility will be assessed qualitatively through post-intervention in-depth interviews.

Study Sites (1)

Loading locations...

Similar Trials